Treatment of ACEi-induced angioedema
Frontiers | Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection - ScienceDirect
Vascular Angiotensin-Converting Enzyme 2 | Circulation Research
Bradykinin-Mediated Angioedema | NEJM
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance - Sriram - 2020 - British Journal of Pharmacology - Wiley Online Library
Frontiers | A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency
JCI - Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2 | Journal of Human Hypertension
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
Angioedema And Angiotensin-Converting Enzyme (ACE) Inhibitors | American Board of Family Medicine
Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment: Molecular Therapy - Methods & Clinical Development
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease - ScienceDirect
Vaccines | Free Full-Text | A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets
IJMS | Free Full-Text | Vitamin D and COVID-19: An Overview of Recent Evidence
Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function | npj Aging
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients | PLOS ONE
Effect of B12 and folate deficiency in hypomethylation of Angiotensin I converting enzyme 2 gene and severity of disease among the acute respiratory distress syndrome patients - Najafipour - Journal of Clinical
Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers? | Cleveland Clinic Journal of Medicine
Kidney and Lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19 | bioRxiv
Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance | PNAS
Viruses | Free Full-Text | ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
Acquired Angioedema Due to C1 Inhibitor Deficiency: Background, Pathophysiology, Etiology
